PTPN6 and breast carcinoma: The low expression of PTPN6 was significantly associated with poor overall survival in bladder cancer patients and co-expression with TNFRSF14 (tumor necrosis factor receptor superfamily member 14) had a close correlation in breast cancer (Menezes et al., 2020).